Literature DB >> 28658875

Efficacy of Perfusion Computed Tomography (PCT) in Differentiating High-Grade Gliomas from Low Grade Gliomas, Lymphomas, Metastases and Abscess.

Lakshmikanth Halegubbi Karegowda1, Rajagopal Kadavigere2, Poonam Mohan Shenoy3, Samir Mustaffa Paruthikunnan1.   

Abstract

INTRODUCTION: Tumoural angioneogenesis and its quantification are important in predicting the tumour grade and in the management with respect to the treatment available and to assess the response to treatment and the prognosis. It also plays major role in the growth and spread of tumours. Hence, a need arises for non-invasive in vivo methods to assess tumour angioneogenesis and tumour grade at the time of presentation and for monitoring the response during treatment and follow up. In this regard Perfusion Computed Tomography (PCT) can be easily added into routine CT studies to obtain such information on lesion physiology along with its morphology. AIM: Prospective evaluation of the efficacy of PCT in differentiating high grade gliomas from low grade glioma lymphomas, metastases and abscess.
MATERIALS AND METHODS: Perfusion CT was performed in 68 patients (17 high-grade gliomas, 10 low-grade gliomas, 7 lymphomas, 27 metastases and 7 abscess). Perfusion parameters which include Cerebral Blood Volume (CBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT) and Time To Peak (TTP) were derived both from the lesion and the normal parenchyma and were Normalized (n) by obtaining the ratio. Statistical analysis for high grade versus low-grade gliomas, high grade gliomas versus lymphomas, metastases and abscess was performed.
RESULTS: Difference in the mean nCBV and nCBF in high grade gliomas were statistically significant from low grade gliomas with cut off of > 3.07 for nCBV and > 2.08 for nCBF yielding good sensitivity and specificity. Difference in the mean nCBV and nMTT in the lymphomas were statistically significant from high grade gliomas (p<0.05) with cut off of <3.40 for nCBV and >1.83 for nMTT yielding good sensitivity and specificity. Difference in the mean nCBV and nMTT in the metastases were statistically significant from high grade gliomas (p<0.05) with cut off of >4.95 for nCBV and >1.88 for nMTT yielding a fair sensitivity and specificity. No statistical significant difference seen among the parameters in differentiating high grade gliomas and abscess.
CONCLUSION: Cerebral PCT greatly adds to the diagnostic accuracy when the diagnosis of a common intra-axial lesion based on morphological characters becomes uncertain.

Entities:  

Keywords:  Cerebral blood flow; Cerebral blood volume; Mean transit time; Time to peak

Year:  2017        PMID: 28658875      PMCID: PMC5483777          DOI: 10.7860/JCDR/2017/24835.9917

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  20 in total

1.  Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI.

Authors:  Thomas M Holmes; Jeffrey R Petrella; James M Provenzale
Journal:  AJR Am J Roentgenol       Date:  2004-11       Impact factor: 3.959

2.  Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.

Authors:  Bei Ding; Hua Wei Ling; Ke Min Chen; Hong Jiang; Yan Bo Zhu
Journal:  Neuroradiology       Date:  2006-08-26       Impact factor: 2.804

3.  Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases.

Authors:  Heidi C Roberts; Timothy P L Roberts; Ting-Yim Lee; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

Review 4.  Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults.

Authors:  Riyadh N Al-Okaili; Jaroslaw Krejza; Sumei Wang; John H Woo; Elias R Melhem
Journal:  Radiographics       Date:  2006-10       Impact factor: 5.333

5.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

6.  Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas.

Authors:  Peter Schramm; Argyro Xyda; Ernst Klotz; Volker Tronnier; Michael Knauth; Marius Hartmann
Journal:  Eur Radiol       Date:  2010-05-22       Impact factor: 5.315

7.  Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Authors:  R Jain; S K Ellika; L Scarpace; L R Schultz; J P Rock; J Gutierrez; S C Patel; J Ewing; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

8.  Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats.

Authors:  Sith Phongkitkarun; Satoshi Kobayashi; Zuxing Kan; Ting-Yim Lee; Chusilp Charnsangavej
Journal:  Acad Radiol       Date:  2004-05       Impact factor: 3.173

9.  Role of dynamic CT perfusion study in evaluating various intracranial space-occupying lesions.

Authors:  Ravindra B Kamble; Peruvumba N Jayakumar; Ravishankar Shivashankar
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

10.  Reproducibility of quantitative CT perfusion imaging.

Authors:  J H Gillard; N M Antoun; N G Burnet; J D Pickard
Journal:  Br J Radiol       Date:  2001-06       Impact factor: 3.039

View more
  2 in total

1.  Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status.

Authors:  Ke Wang; Yeming Li; Haiyang Cheng; Shenjie Li; Wei Xiang; Yang Ming; Ligang Chen; Jie Zhou
Journal:  BMC Neurol       Date:  2021-11-24       Impact factor: 2.474

Review 2.  Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Authors:  Lelio Guida; Vittorio Stumpo; Jacopo Bellomo; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.